Table 3.
Characteristics of employed and not employed patients after orthotopic liver transplantation
| n = 96 | Employed (n = 43) | Not employed (n = 53) | P value |
| Age median (range, min-max) | 47 (42, 18-60) | 50 (31, 29-60) | 0.01 |
| Sex (male/female) | 23 (53.5%)/20 | 36 (67.9%)/17 | 0.21 |
| Profession Academic/non-academic | 13 (31.0%)/29 (NS 1) | 8 (15.1%)/45 | 0.08 |
| labMELD median (range, min-max) | 18 (33, 7-40) | 19 (33, 7-40) | 0.16 |
| Aetiology of liver disease | 0.41 | ||
| PSC | 15 | 13 | |
| PBC | 1 | 0 | |
| Alcohol | 4 | 8 | |
| HCV | 7 | 6 | |
| HBV | 3 | 12 | |
| AIH | 2 | 1 | |
| M. Wilson | 2 | 1 | |
| Others | 9 | 12 | |
| History of HE (+/-) | 13 (30.2%)/30 | 25 (47.2%)/28 | 0.10 |
| Neurological complications (+/-) | 17 (39.5%)/26 | 30 (56.6%)/23 | 0.11 |
| PHES, median (min/max) | 0 (-5/+2) (n = 30) | -1 (-10/+4) (n = 43) | 0.10 |
| CFF, mean ± SD | 45.8 ± 4.0 (n = 29) | 42.0 ± 4.1 (n = 40) | < 0.001 |
| RBANS Immediate memory, mean ± SD | 101.1 ± 15.1 (n = 30) | 92.1 ± 17.7 (n = 41) | 0.03 |
| RBANS Visuospatial/constructional, median (range, min-max) | 84 (64, 62-126) (n = 30) | 89 (57, 64-121) (n = 41) | 0.17 |
| RBANS Language, mean ± SD | 103.2 ± 13.9 (n = 30) | 93.0 ± 16.5 (n = 41) | 0.01 |
| RBANS Attention, mean ± SD | 101.2 ± 13.7 (n = 30) | 89.3 ± 15.5 (n = 41) | 0.001 |
| RBANS Delayed memory, median (range, min-max) | 98 (109, 10-119) (n = 30) | 95 (44, 75-119) (n = 41) | 0.13 |
| RBANS Sum score, mean ± SD | 490.7 ± 48.2 (n = 30) | 461.0 ± 54.5 (n = 41) | 0.02 |
| RBANS Total scale, mean ± SD | 97.4 ± 13.6 (n = 30) | 89.6 ± 14.2 (n = 41) | 0.02 |
P value ≤ 0.05 is considered significant. NS: Not specified; OLT: Orthotopic liver transplantation; labMELD: Laboratory Model of End Stage Liver Disease; PSC: Primary sclerosing cholangitis; PBC: Primary biliary cirrhosis; HCV: Hepatitis C virus; HBV: Hepatitis B virus; AIH: Autoimmune hepatitis; HE: Hepatic encephalopathy; PHES: Psychometric hepatic encephalopathy score; CFF: Critical flicker frequency; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status.